Compare AU
Compare DRUG vs. IEU
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the S&P Europe 350 Large-Caps (IEU). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | IEU | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 57 |
Median incremental investment | $967.00 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,875.72 | $2,123.00 |
Average age group | 26 - 35 | 26 - 35 |
Key Summary
DRUG | IEU | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | IEU.AX was created on 2000-07-25 by iShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to provide investors with the performance of the S&P Europe 350TM Index, before fees and expenses. The index is designed to measure the performance of large capitalisation equities and covers 16 major developed European markets |
Top 3 holdings | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) | ISHARES EUROPE ETF TRUST (99.88 %) AUD CASH (0.11 %) USD CASH (0.02 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | Other (99.93 %) Communication Services (0.07 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | United Kingdom of Great Britain and Northern Ireland (22.73 %) Switzerland (16.15 %) France (15.81 %) |
Management fee | 0.57 % | 0.59 % |
Key Summary
DRUG | IEU | |
|---|---|---|
Issuer | BetaShares | iShares |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | S&P Europe 350 Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.59 % |
Price | $8.12 | $84.92 |
Size | $191.120 million | $735.335 million |
10Y return | N/A | 64.29 % |
Annual distribution yield (5Y) | 1.90 % | 2.40 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 10/10/2007 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | IEU | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 57 |
Median incremental investment | $967.00 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,875.72 | $2,123.00 |
Average age group | 26 - 35 | 26 - 35 |
Pros and Cons
DRUG | IEU | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRUG | IEU |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |